Study Title: Phase 3 Study of Ficlatuzumab in Combination with Cetuximab in Subjects with Recurrent or Metastatic (R/M) HPV-Negative Head and Neck Squamous Cell Carcinoma (FIERCE-HN)
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, John Kaczmar, at kaczmar@musc.edu, or please call +1 843-792-6691.Study Coordinator, Madison Avinger, at avingerm@musc.edu.Trial opened at the following institutions: Medical University of South Carolina